Paul Yeung, M.D., M.P.H.

Dr. Paul Yeung is Neumora’s Senior Vice President and Head of Clinical Development, leading clinical strategy and execution across development programs and overseeing the biometrics function to support clinical decision-making. Dr. Yeung brings 30 years of neuroscience clinical development and medical affairs experience to Neumora. Prior to joining Neumora, Dr. Yeung served as Senior Vice President, Clinical Development at Karuna Therapeutics, which was acquired by Bristol Myers Squibb in 2024.  Previously, he held multiple leadership roles at AbbVie, Actelion, AstraZeneca, Bristol Myers Squibb, Teva, and Wyeth (now Pfizer).  Dr. Yeung earned his Master of Public Health (M.P.H.) and Doctor of Medicine (M.D.) degrees from Columbia University College of Physicians and Surgeons in New York City, and he completed his medical training at Yale University School of Medicine.  He also served on the adjunct clinical faculty at Yale and at University of Pennsylvania School of Medicine.